Category Archives: Active Surveillance

Enzalutamide monotherapy in Hormone-Naïve Prostate Cancer

Posted on July 12, 2015 by

Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer.

Posted in Active Surveillance, Hormonal Blockade, Metastatic Disease, Prostate Cancer, Treatments for Prostate Cancer | Tagged , , | Leave a comment

Active Surveillance In Intermediate-Risk Prostate Cancer

Posted on April 6, 2015 by

Active Surveillance In Intermediate-Risk Prostate Cancer Called Into Question. https://youtu.be/dBk3z2T9KwQ Dr. Israel Barken brings info about higher risk of cancer specific mortality in the intermediate prostate cancer risk group. The study presentor at the GenitoUrinary Symposium 2015 was Dr. Andrew … Continue reading →

Posted in Active Surveillance, Treatments for Prostate Cancer | Tagged , | 1 Comment

Prostvac Vaccination for Localized Prostate Cancer Disease

Posted on March 6, 2015 by

Prostvac in Preventing Disease Progression in Patients with Localized Cancer Undergoing Active Surveillance. What is unique about  this vaccine study , is the fact that it is given to patients with localized disease.  Practically, the patient gets a series of vaccination … Continue reading →

Posted in Active Surveillance, Clinical Trials, Immune Therapy, Treatments for Prostate Cancer, Vaccine | Tagged , | Leave a comment

Phase III Prostvac Clinical Study

Posted on December 18, 2014 by

Immune Therapy is an important tool for advanced prostate cancer disease, especially in older patients for whom chemotherapy is excluded because of other serious medical problems. Dr. Barken presents the Prostvac Clinical Study Phase III with a video clip featuring … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Metastatic Disease, Prostate Cancer, PSA | Leave a comment

Long Term Results of Optimized Focal Cryotherapy

Posted on December 4, 2014 by

Long Term Results of Optimized Focal Cryotherapy These days, there is a lot of interest in using focal therapy for prostate cancer. There are a number of modalities to achieve the destruction of the tumor locally within the prostate. Obviously … Continue reading →

Posted in Active Surveillance, Focal Therapy, Prostate Cancer, Treatments for Prostate Cancer | Tagged , , , | Leave a comment

Prostate Cancer Convention 2014

Posted on August 19, 2014 by

Dr. Israel Barken, the medical director of the prostate cancer research and education foundation is interviewing Dr. Mark Scholz from the Prostate Cancer Research Institute about this year Prostate Cancer Convention.  

Posted in Active Surveillance, Hormonal Blockade, Treatments for Prostate Cancer | Tagged , | 2 Comments

Active Surveillance- Canadian Experience Part 2.

Posted on May 9, 2014 by

  Active Surveillance:  Current status and future direction. Part 2. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday.      Click here to send me a question by sending a video.  Click to view instructions.

Posted in Active Surveillance, Biopsy, Imaging, PSA, Treatments for Prostate Cancer | Leave a comment

Active Surveillance- Canadian Experience

Posted on May 3, 2014 by

Active Surveillance:  Current status and future direction. Part 1. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday.         Click here to send me a question by sending a video. Click to view instructions.

Posted in Active Surveillance, Biomarker, Imaging, MRI, Multi Parameteric MRI | Leave a comment

Active Surveillance: Contemporary Recommendation

Posted on April 20, 2014 by

Article written by Peter C. Albertsen, M.D.,  AUA News April 2014  

Posted in Active Surveillance, Treatments for Prostate Cancer | Tagged | Leave a comment

Active Surveillance – Interview with Dr. Richard Lam

Posted on August 12, 2013 by
Posted in Active Surveillance, Biomarker, Treatments for Prostate Cancer | Leave a comment